Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol: Effects on the lipid profile

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 3, 2003, Pages 179-186

  Creasy, George W ^a   Fisher, Alan C ^a   Hall, Nancy ^a   Shangold, Gary A ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Contraceptive devices, female; Ethinyl estradiol; Lipids; Norelgestromin

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MEDROXYPROGESTERONE ACETATE; NORELGESTROMIN; TRI CILEST; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MASTALGIA; MENTAL INSTABILITY; METRORRHAGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC CIRCULATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONTRACEPTIVES, ORAL, COMBINED; DOUBLE-BLIND METHOD; ETHINYL ESTRADIOL; ETHISTERONE; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NORGESTREL; OXIMES; REFERENCE VALUES; TIME FACTORS; TRIGLYCERIDES;

EID: 0037348396     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hatcher RA, Guillebaud J: The pill: Combined oral contraceptives. In Contraceptive Technology. Edited by RA Hatcher, J Trussell, F Stewart, et al. New York, Ardent Media, 1998, pp 405-466
2. Godsland IF, Crook D, Simpson R, et al: The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990;323:1375-1381
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497
4. International Task Force for Prevention of Coronary Heart Disease: Prevention of coronary heart disease: Scientific background and new clinical guidelines: Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis 1992;2:113-156
5. Phillips A, Demarest K, Hahn DW, et al: Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 1990;41:399-410
6. Teichmann A: Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Int J Fertil Menopausal Stud (suppl 2) 1995;40:98-104
7. Andolsek KM, Burkman RTJ, Kafrissen ME, et al: Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol). Int J Fertil Menopausal Stud (suppl 3) 1993;38:122-125
8. Janaud A, Rouffy J, Upmalis D, et al: A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel. Acta Obstet Gynecol Scand (suppl) 1992;156:33-38
9. Burkman RT Jr, Kafrissen ME, Olson W, et al: Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate. Acta Obstet Gynecol Scand (suppl) 1992;156:5-8
10. Chapdelaine A, Desmarais J-L, Derman RJ: Clinical evidence of the minimal androgenic activity of norgestimate. Int J Fertil 1989;34:347-352
11. Sulak P, Lippman J, Siu C, et al: Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol: Cycle control, lipid effects, and user satisfaction. Contraception 1999;59:161-166
12. Abrams LS, Skee D, Natarajan J, et al: Pharmacokinetic overview of Ortho Evra™/Evra™. Fertil Steril (suppl 2) 2002;77:S3-S12
13. Zieman M, Guillebaud J, Weisberg E, et al: Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: The analysis of pooled data. Fertil Steril (suppl 2) 2002;77:S13-S18
14. Sibai BM, Odlind V, Meador ML, et al: A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™). Fertil Steril (suppl 2) 2002;77:S19-S26
15. Archer DF, Bigrigg A, Smallwood GH, et al: Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women. Fertil Steril (suppl 2) 2002;77:S27-S31
16. Zacur HA, Hedon B, Mansour D, et al: Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril (suppl 2) 2002;77: S32-S35
17. Abrams L, Skee D, Talluri K, et al: Bioavailability of 17-deacetylnorgestimate (17D-NGM) and ethinyl estradiol (EE) from a contraceptive patch (abstr). FASEB J 2000;14:A1479
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
19. Warnick GR, Knopp RH, Fitzpatrick V, et al: Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990;36:15-19
20. Gordon DJ, Probstfield JL, Garrison RJ, et al: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
21. Gotto AM Jr: Triglyceride as a risk factor for coronary artery disease. Am J Cardiol 1998;82:22Q-25Q
22. Audet M-C, Moreau M, Koltun WD, et al: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: A randomized controlled trial. JAMA 2001;285:2347-2354
23. Hedon B, Helmerhorst FM, Cronje HS, et al: Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptive (abstr). Int J Gynecol Obstet (suppl 1) 2000;70:78
24. Smallwood GH, Meador ML, Lenihan JP Jr, et al: Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001;98:799-805